Background: No single modality of treatment for breast cancer can be the mainstay of therapy. One of them is breast conservation treatment (BCT) comprises BCS and whole breast radiotherapy. BCT is not popular among the surgeons in India (11-23% vs. > 60-70% in west). The advantages of BCS over MRM include, better body image, sexual functioning and better psychological adjustment. In view of this, the present study was undertaken to highlight the importance of BCT and comparison of post-operative events with MRM. Aim And Objective: To evaluate the possibility of BCT in cases of LABC after neo-adjuvant chemotherapy. To compare BCT with MRM in terms of quality of life and postoperative complications. Patients And Methods: The study was carried out in the PG department of General Surgery and Oncosurgery Wing of M.K.C.G. Medical College & Hospital from August 2018 to June 2021 (including 12 months of follow up period).Total no of cases included in this study are 20. We have selected stage I & II and few cases of stage III A for our study. Results: In our study, as the study period is only 2 years and follow-up period was only 12 month, so overall survival is 100% for both BCT & MRM. Recurrence rate for BCT is 15% and for MRM is 5%. Out of Several studies maximum show that overall survival rate for both BCT and MRM group are almost same and comparable. Recurrence rate in case of BCT is high as compared to MRM except in study of Fisher et al and Blichert-Toft et al where recurrence rate in MRM is high. Conclusion: It is a challenge for a surgeon to do BCS in early breast cancer case, as till now both the patients and the surgeons are in favour of MRM for reasons of safety and due to fear of recurrences. We felt that both the surgeons in the periphery and the women folks need to be made aware about the huge benefits of BCT in comparison to MRM. While selecting the patients, proper criteria must be adhered to. Radiation is a must after BCT but failing, for which the incidence of local recurrences goes up